You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Olanzapine suppresses insulin secretion from pancreatic β-cells via blockade of multiple receptors
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-PAA-011
- By: NAGATA, Mao (Graduate School of Biomedical & Health Sciences, Hiroshima University, Department of Pharmaceutical Services)
- Co-author(s): Mao Nagata: Department of Pharmaceutical Services, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
Tomoe Nakai: School of Pharmaceutical Sciences, Hiroshima University, Hiroshima, Japan
Yumika Miura: School of Pharmaceutical Sciences, Hiroshima University, Hiroshima, Japan
Takashi Tomita: Department of Pharmaceutical Services, Hiroshima University Hospital, Hiroshima, Japan
Takanori Taogoshi: Department of Pharmaceutical Services, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan;School of Pharmaceutical Sciences, Hiroshima University, Hiroshima, Japan;Department of Pharmaceutical Services, Hiroshima University Hospital, Hiroshima, Japan
Tomoharu Yokooji: Department of Pharmaceutical Services, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan;School of Pharmaceutical Sciences, Hiroshima University, Hiroshima, Japan
Yumi Sugimoto: Department of Pharmacology, Himeji Dokkyo University, Hyogo, Japan
Hiroaki Matsuo: Department of Pharmaceutical Services, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan;School of Pharmaceutical Sciences, Hiroshima University, Hiroshima, Japan;Department of Pharmaceutical Services, Hiroshima University Hospital, Hiroshima, Japan - Abstract:
Background
Olanzapine is a potent antipsychotic agent which blocks multiple receptors such as dopamine, serotonin and histamine receptors. The use of olanzapine is sometime limited due to the induction of hyperglycemia as a side effect.Methods
Expressions of dopamine (D2, D3 and 4), serotonin (5-HT2A, 5-HT2B, 5-HT2C and 5-HT6) and histamine H1.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026